Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany.

@article{Kostev2012PredictorsFT,
  title={Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany.},
  author={Karel Kostev and Franz-Werner Dippel},
  journal={Primary care diabetes},
  year={2012},
  volume={6 4},
  pages={
          329-35
        }
}
OBJECTIVE To assess the predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany. RESEARCH DESIGN AND METHODS A historical cohort study based on representative German real life data (IMS(®) Disease Analyzer) was performed. The study included patients with type 2 diabetes who started an oral antidiabetic drug (OAD) treatment between 01/1995 and 12/2011. Patients with consecutive treatment data for at least 12 months… CONTINUE READING
BETA

Figures, Tables, and Topics from this paper.

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Factors associated with switching from oral hypoglycaemic agents to insulin therapy, Netherlands

J. A. Spoelstra, R. P. Stol, M. C. de Bruyne
  • Journal of Medicine
  • 2002
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

A

S. Matthaei, R. Bierwirth
  • Fritsche, et al., Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association, Experimental and Clinical Endocrinology and Diabetes 117
  • 2009

ADea

E. G. Hagenmeyer, P. K. Schädlich
  • Köster, Lebensqualität und Behandlungszufriedenheit unter langwirksamen Analoginsulinen. Systhematischer Review, Deutsche Medizinische Wochenschrift 133
  • 2009
VIEW 1 EXCERPT

C

N. Perez, J. Moisan
  • Sirois, et al., Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs, CMAJ 180
  • 2009
VIEW 3 EXCERPTS

Insulin glargin mit oralen Antidiabetika: Vorteilhafter Einstieg in die Insulintherapie

S. Kress, F. Dippel, K. Kostev
  • Diabetes, Stoffwechsel und Herz 18
  • 2009

W

H. Hauner, T. Kohlmann
  • Landgraf, et al., Kosten für antihyperglykämische Arznei- und Verbrauchsmittel und Therapiezufriedenheit bei Typ-2-Diabetes. Ergebnisse der Versorgungsforschungsstudie LIVE-DE, Deutsche Medizinische Wochenschrift 134
  • 2009
VIEW 1 EXCERPT